Delivery Order SPE2DB20D2104-SPE2DB25FMVVQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,828.45 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was awarded on July 18, 2025. No set-aside designation was used in this competitive award. Performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product. The contract has a ceiling value of $1,770.81 and is a firm fixed-price delivery order with a performance period ending on April 17, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product, with a ceiling value of $1,310.22. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply AIRSUPRA 90-80 MCG INHALER 10.7GM. The $1,859.88 order has an ultimate completion date of April 3, 2024 and is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen. The IDC, valued up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product AIRSUPRA 90-80 MCG INHALER 10.7GM. The contract has a ceiling value of $1,974.40 and a performance period ending on May 15, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.19 firm fixed-price contract is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a performance period ending on December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,867.32, is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM medical supplies. The contract has an ultimate completion date of January 29, 2025 and is a Firm Fixed Price Delivery Order. No set-aside was used for this award. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a $2,651.89 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM medical devices and has a completion date of February 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of an AIRSUPRA 90-80 MCG INHALER 10.7GM, with a ceiling value of $1,143.81 and an ultimate completion date of June 6, 2025. This delivery order is not associated with any set-aside program. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the AIRSUPRA 90-80 MCG INHALER 10.7GM medical product. The contract has a ceiling value of $1,326.87 and a period of performance through July 10, 2025. This order is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVVQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,740.00 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM, with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under DLA's medical procurement operations, which support military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial portfolio of federal contract awards demonstrating its capability to meet competitive federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/18/25 |